# COVID-19 neurological impacts and Alzheimer’s research

> Live situation record from CLSTR: https://clstr.news/situations/covid-19-neurological-impacts-and-alzheimers-research
> Updated: 2026-08-14T20:05:43.000Z. Sources: 5. Developments: 2.

Medical discussions have focused on the neurological impacts of COVID-19 and advancements in Alzheimer’s diagnostics. Neurologist Jamyllo Sales noted that the virus may reach the brain via the olfactory bulb, triggering neuroinflammation that increases the risk of neurodegeneration and memory impairment. He also highlighted how pandemic-related stress and isolation contribute to cognitive issues.

Further research suggests that severe COVID-19 may trigger the reactivation of dormant viruses, such as Herpesviridae and Epstein-Barr, which may contribute to Long COVID symptoms. In parallel, the FDA’s approval of blood biomarker tests for Alzheimer’s, such as those measuring p-tau217 proteins, has provided new diagnostic utility while simultaneously causing psychological distress due to the non-definitive nature of the results.

## Timeline

### 2026-08-14: Medical research highlights COVID-19 virus reactivation and Alzheimer's testing concerns

Medical updates highlight COVID-19's potential to reactivate dormant viruses, the psychological impact of new Alzheimer's blood tests, and the importance of early menopause awareness in women's 30s.

5 sources. https://clstr.news/cluster/womens-health-experts-highlight-menopause-risks-and-alzheimers-links

### 2026-07-31: Neurologist Jamyllo Sales warns COVID-19 worsens memory loss and Alzheimer risk

Neurologist Jamyllo Sales says COVID‑19 can cause neuroinflammation, raising early forgetting and Alzheimer risk, especially amid pandemic‑related stress.

2 sources. https://clstr.news/cluster/neurologist-jamyllo-sales-warns-covid-19-worsens-memory-loss-and-alzheimer-risk

---
Cite as: COVID-19 neurological impacts and Alzheimer’s research. CLSTR, https://clstr.news/situations/covid-19-neurological-impacts-and-alzheimers-research